Cargando…

Mammographic breast density and risk of breast cancer in women with atypical hyperplasia: an observational cohort study from the Mayo Clinic Benign Breast Disease (BBD) cohort

BACKGROUND: Atypical hyperplasia (AH) and mammographic breast density (MBD) are established risk factors for breast cancer (BC), but their joint contributions are not well understood. We examine associations of MBD and BC by histologic impression, including AH, in a subcohort of women from the Mayo...

Descripción completa

Detalles Bibliográficos
Autores principales: Vierkant, Robert A., Degnim, Amy C., Radisky, Derek C., Visscher, Daniel W., Heinzen, Ethan P., Frank, Ryan D., Winham, Stacey J., Frost, Marlene H., Scott, Christopher G., Jensen, Matthew R., Ghosh, Karthik, Manduca, Armando, Brandt, Kathleen R., Whaley, Dana H., Hartmann, Lynn C., Vachon, Celine M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5282712/
https://www.ncbi.nlm.nih.gov/pubmed/28143431
http://dx.doi.org/10.1186/s12885-017-3082-2
_version_ 1782503377205198848
author Vierkant, Robert A.
Degnim, Amy C.
Radisky, Derek C.
Visscher, Daniel W.
Heinzen, Ethan P.
Frank, Ryan D.
Winham, Stacey J.
Frost, Marlene H.
Scott, Christopher G.
Jensen, Matthew R.
Ghosh, Karthik
Manduca, Armando
Brandt, Kathleen R.
Whaley, Dana H.
Hartmann, Lynn C.
Vachon, Celine M.
author_facet Vierkant, Robert A.
Degnim, Amy C.
Radisky, Derek C.
Visscher, Daniel W.
Heinzen, Ethan P.
Frank, Ryan D.
Winham, Stacey J.
Frost, Marlene H.
Scott, Christopher G.
Jensen, Matthew R.
Ghosh, Karthik
Manduca, Armando
Brandt, Kathleen R.
Whaley, Dana H.
Hartmann, Lynn C.
Vachon, Celine M.
author_sort Vierkant, Robert A.
collection PubMed
description BACKGROUND: Atypical hyperplasia (AH) and mammographic breast density (MBD) are established risk factors for breast cancer (BC), but their joint contributions are not well understood. We examine associations of MBD and BC by histologic impression, including AH, in a subcohort of women from the Mayo Clinic Benign Breast Disease Cohort. METHODS: Women with a diagnosis of BBD and mammogram between 1985 and 2001 were eligible. Histologic impression was assessed via pathology review and coded as non-proliferative disease (NP), proliferative disease without atypia (PDWA) and AH. MBD was assessed clinically using parenchymal pattern (PP) or BI-RADS criteria and categorized as low, moderate or high. Percent density (PD) was also available for a subset of women. BC and clinical information were obtained by questionnaires, medical records and the Mayo Clinic Tumor Registry. Women were followed from date of benign biopsy to BC, death or last contact. Standardized incidence ratios (SIRs) compared the observed number of BCs to expected counts. Cox regression estimated multivariate-adjusted MBD hazard ratios. RESULTS: Of the 6271 women included in the study, 1132 (18.0%) had low MBD, 2921 (46.6%) had moderate MBD, and 2218 (35.4%) had high MBD. A total of 3532 women (56.3%) had NP, 2269 (36.2%) had PDWA and 470 (7.5%) had AH. Over a median follow-up of 14.3 years, 528 BCs were observed. The association of MBD and BC risk differed by histologic impression (p-interaction = 0.03), such that there was a strong MBD and BC association among NP (p < 0.001) but non-significant associations for PDWA (p = 0.27) and AH (p = 0.96). MBD and BC associations for AH women were not significant within subsets defined by type of MBD measure (PP vs. BI-RADS), age at biopsy, number of foci of AH, type of AH (lobular vs. ductal) and body mass index, and after adjustment for potential confounding variables. Women with atypia who also had high PD (>50%) demonstrated marginal evidence of increased BC risk (SIR 4.98), but results were not statistically significant. CONCLUSION: We found no evidence of an association between MBD and subsequent BC risk in women with AH. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-017-3082-2) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5282712
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-52827122017-02-03 Mammographic breast density and risk of breast cancer in women with atypical hyperplasia: an observational cohort study from the Mayo Clinic Benign Breast Disease (BBD) cohort Vierkant, Robert A. Degnim, Amy C. Radisky, Derek C. Visscher, Daniel W. Heinzen, Ethan P. Frank, Ryan D. Winham, Stacey J. Frost, Marlene H. Scott, Christopher G. Jensen, Matthew R. Ghosh, Karthik Manduca, Armando Brandt, Kathleen R. Whaley, Dana H. Hartmann, Lynn C. Vachon, Celine M. BMC Cancer Research Article BACKGROUND: Atypical hyperplasia (AH) and mammographic breast density (MBD) are established risk factors for breast cancer (BC), but their joint contributions are not well understood. We examine associations of MBD and BC by histologic impression, including AH, in a subcohort of women from the Mayo Clinic Benign Breast Disease Cohort. METHODS: Women with a diagnosis of BBD and mammogram between 1985 and 2001 were eligible. Histologic impression was assessed via pathology review and coded as non-proliferative disease (NP), proliferative disease without atypia (PDWA) and AH. MBD was assessed clinically using parenchymal pattern (PP) or BI-RADS criteria and categorized as low, moderate or high. Percent density (PD) was also available for a subset of women. BC and clinical information were obtained by questionnaires, medical records and the Mayo Clinic Tumor Registry. Women were followed from date of benign biopsy to BC, death or last contact. Standardized incidence ratios (SIRs) compared the observed number of BCs to expected counts. Cox regression estimated multivariate-adjusted MBD hazard ratios. RESULTS: Of the 6271 women included in the study, 1132 (18.0%) had low MBD, 2921 (46.6%) had moderate MBD, and 2218 (35.4%) had high MBD. A total of 3532 women (56.3%) had NP, 2269 (36.2%) had PDWA and 470 (7.5%) had AH. Over a median follow-up of 14.3 years, 528 BCs were observed. The association of MBD and BC risk differed by histologic impression (p-interaction = 0.03), such that there was a strong MBD and BC association among NP (p < 0.001) but non-significant associations for PDWA (p = 0.27) and AH (p = 0.96). MBD and BC associations for AH women were not significant within subsets defined by type of MBD measure (PP vs. BI-RADS), age at biopsy, number of foci of AH, type of AH (lobular vs. ductal) and body mass index, and after adjustment for potential confounding variables. Women with atypia who also had high PD (>50%) demonstrated marginal evidence of increased BC risk (SIR 4.98), but results were not statistically significant. CONCLUSION: We found no evidence of an association between MBD and subsequent BC risk in women with AH. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-017-3082-2) contains supplementary material, which is available to authorized users. BioMed Central 2017-01-31 /pmc/articles/PMC5282712/ /pubmed/28143431 http://dx.doi.org/10.1186/s12885-017-3082-2 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Vierkant, Robert A.
Degnim, Amy C.
Radisky, Derek C.
Visscher, Daniel W.
Heinzen, Ethan P.
Frank, Ryan D.
Winham, Stacey J.
Frost, Marlene H.
Scott, Christopher G.
Jensen, Matthew R.
Ghosh, Karthik
Manduca, Armando
Brandt, Kathleen R.
Whaley, Dana H.
Hartmann, Lynn C.
Vachon, Celine M.
Mammographic breast density and risk of breast cancer in women with atypical hyperplasia: an observational cohort study from the Mayo Clinic Benign Breast Disease (BBD) cohort
title Mammographic breast density and risk of breast cancer in women with atypical hyperplasia: an observational cohort study from the Mayo Clinic Benign Breast Disease (BBD) cohort
title_full Mammographic breast density and risk of breast cancer in women with atypical hyperplasia: an observational cohort study from the Mayo Clinic Benign Breast Disease (BBD) cohort
title_fullStr Mammographic breast density and risk of breast cancer in women with atypical hyperplasia: an observational cohort study from the Mayo Clinic Benign Breast Disease (BBD) cohort
title_full_unstemmed Mammographic breast density and risk of breast cancer in women with atypical hyperplasia: an observational cohort study from the Mayo Clinic Benign Breast Disease (BBD) cohort
title_short Mammographic breast density and risk of breast cancer in women with atypical hyperplasia: an observational cohort study from the Mayo Clinic Benign Breast Disease (BBD) cohort
title_sort mammographic breast density and risk of breast cancer in women with atypical hyperplasia: an observational cohort study from the mayo clinic benign breast disease (bbd) cohort
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5282712/
https://www.ncbi.nlm.nih.gov/pubmed/28143431
http://dx.doi.org/10.1186/s12885-017-3082-2
work_keys_str_mv AT vierkantroberta mammographicbreastdensityandriskofbreastcancerinwomenwithatypicalhyperplasiaanobservationalcohortstudyfromthemayoclinicbenignbreastdiseasebbdcohort
AT degnimamyc mammographicbreastdensityandriskofbreastcancerinwomenwithatypicalhyperplasiaanobservationalcohortstudyfromthemayoclinicbenignbreastdiseasebbdcohort
AT radiskyderekc mammographicbreastdensityandriskofbreastcancerinwomenwithatypicalhyperplasiaanobservationalcohortstudyfromthemayoclinicbenignbreastdiseasebbdcohort
AT visscherdanielw mammographicbreastdensityandriskofbreastcancerinwomenwithatypicalhyperplasiaanobservationalcohortstudyfromthemayoclinicbenignbreastdiseasebbdcohort
AT heinzenethanp mammographicbreastdensityandriskofbreastcancerinwomenwithatypicalhyperplasiaanobservationalcohortstudyfromthemayoclinicbenignbreastdiseasebbdcohort
AT frankryand mammographicbreastdensityandriskofbreastcancerinwomenwithatypicalhyperplasiaanobservationalcohortstudyfromthemayoclinicbenignbreastdiseasebbdcohort
AT winhamstaceyj mammographicbreastdensityandriskofbreastcancerinwomenwithatypicalhyperplasiaanobservationalcohortstudyfromthemayoclinicbenignbreastdiseasebbdcohort
AT frostmarleneh mammographicbreastdensityandriskofbreastcancerinwomenwithatypicalhyperplasiaanobservationalcohortstudyfromthemayoclinicbenignbreastdiseasebbdcohort
AT scottchristopherg mammographicbreastdensityandriskofbreastcancerinwomenwithatypicalhyperplasiaanobservationalcohortstudyfromthemayoclinicbenignbreastdiseasebbdcohort
AT jensenmatthewr mammographicbreastdensityandriskofbreastcancerinwomenwithatypicalhyperplasiaanobservationalcohortstudyfromthemayoclinicbenignbreastdiseasebbdcohort
AT ghoshkarthik mammographicbreastdensityandriskofbreastcancerinwomenwithatypicalhyperplasiaanobservationalcohortstudyfromthemayoclinicbenignbreastdiseasebbdcohort
AT manducaarmando mammographicbreastdensityandriskofbreastcancerinwomenwithatypicalhyperplasiaanobservationalcohortstudyfromthemayoclinicbenignbreastdiseasebbdcohort
AT brandtkathleenr mammographicbreastdensityandriskofbreastcancerinwomenwithatypicalhyperplasiaanobservationalcohortstudyfromthemayoclinicbenignbreastdiseasebbdcohort
AT whaleydanah mammographicbreastdensityandriskofbreastcancerinwomenwithatypicalhyperplasiaanobservationalcohortstudyfromthemayoclinicbenignbreastdiseasebbdcohort
AT hartmannlynnc mammographicbreastdensityandriskofbreastcancerinwomenwithatypicalhyperplasiaanobservationalcohortstudyfromthemayoclinicbenignbreastdiseasebbdcohort
AT vachoncelinem mammographicbreastdensityandriskofbreastcancerinwomenwithatypicalhyperplasiaanobservationalcohortstudyfromthemayoclinicbenignbreastdiseasebbdcohort